Table 5 (Comparison of influence of therapy on the 3 categories of patients)
From: Outcome of coronary plaque burden: a 10-year follow-up of aggressive medical management
PARAMETER | Patients untreated for Hypercholesterolaemia | Patients on Statins alone | Patients on Statins + Risk Factor Modification (RFM) | ||
|---|---|---|---|---|---|
Change in Total Cholesterol after intervention | Nil | Nil | Nil | ||
Change in HDL Cholesterol after intervention | Nil | Nil | Nil | ||
Change in LDL Cholesterol after intervention | Nil | Nil | Nil | ||
Change in Triglycerides after intervention | Nil | Nil | Nil | ||
Change in Calcium score with intervention | Nil | 52/70 patients (= 74.3%) progressed in Calcium score on Statins alone 18/23 patients (= 78.3%) regressed in Calcium score on Statins | 18/70 patients (= 25.7%) progressed in calcium score on Statins + RFM 5/23 patients (= 21.7%) regressed in calcium score on Statins + RFM | ||
PARAMETERS | Patients untreated for Hypercholesterolaemia | Rising Ca score on statins alone | Decreasing Ca score on statins alone | Rising Ca score on statins + RFM | Decreasing Ca score on statins + RFM |
No. of Patients | 7 | 52 out of 70 patients (= 74.3%) | 18 out of 23 patients (= 78.3%) | 18 out of 70 patients (= 25.7%) | 5 out of 23 patients (= 21.7%) |
Calcium score | Zero at baseline and zero on follow-up | From a mean calcium score of 111.7 to 301.2 (+169.7%) | From a mean calcium score of 276.2 to 194.9 (-29.4%) | From a mean calcium score of 89.17 to 147.6 (+65.5%) | From a mean calcium score of 26.7 to 19.5 (-27%) |